SMJ : September 2020 Vol. 113, No. 09

September 8, 2020 // Randy Glick

The Southern Medical Journal(SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists, including medicine; surgery; women’s and children’s health; mental health; emergency and disaster medicine; public health and environmental medicine; bioethics and medical education; and quality health care, patient safety, and best practices.

Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates

Samuel O. Schumann, MD, MSCR, Jingwen Zhang, MS, Jenna L. McCauley, PhD, Khosrow Heidari, MS, Sarah J. Ball, PharmD

Global Health Lessons from a District Hospital

Masahiro J. Morikawa, MD, MPH

Voting Rights in the Era of COVID-19

Neil J. Nusbaum, JD, MD

Cystic Fibrosis and COVID-19

Kyle D. Chapman, MD, Kathryn S. Moffett, MD

Prediction of Functional Limitations in Balance after Tests of Tandem Walking and Standing Balance in Older Adults

Helen S. Cohen, EdD, OTR, Haleh Sangi-Haghpeykar, PhD, Susan P. Williams, MD

Implications of Frailty among Men with Implantable Cardioverter Defibrillators

Katherine Picel, MD, Tien N. Vo, MS, Jessica Kealhofer, MD, Vidhu Anand, MD, Kristine E. Ensrud, MD, MPH, Selcuk Adabag, MD, MS

Travel Histories in Children: How Well Do Interns and Medical Students Do?

Shaundra Blakemore, MD, Meghan E. Hofto, MD, Nipam Shah, MBBS, MPH, Stacy L. Gaither, MSN, RN, Pranaya Chilukuri, BS, Nancy M. Tofil, MD

Segmental Withdrawal During Screening Colonoscopy Does Not Increase Adenoma Detection Rate

Danny J. Avalos, MD, Yi Jia, MD, PhD, Marc J. Zuckerman, MD, Majd Michael, MD, Jose Gonzalez-Martinez, MD, Antonio Mendoza-Ladd, MD, Cesar J. Garcia, MD, Joseph Sunny, MD, Veronica C. Delgado, RN, Berenice Hernandez, RN, Alok K. Dwivedi, PhD, Indika V. Mallawaarachchi, MS, Christopher Dodoo, MS, Mohamed O. Othman, MD

CME Article: Assessment of Written Feedback for Emergency Medicine Residents

Barry Hahn, MD, Elizabeth D. Waring, MD, Jerel Chacko, MD, Gabriella Trovato, RN, Amanda Tice, RN, Josh Greenstein, MD

Self-Directed Learning among Internal Medicine Residents in the Information Age

Matthew Kelleher, MD, MEd, Rebecca E. Miller, MD, Ashley Duckett, MD, Paul O’Rourke, MD, MPH, Lindsey Hall, MPH, Miao-Shan Yen, MS, Stephanie A. Call, MD, MSPH, Steven E. Bishop, MD, Sean Tackett, MD, MPH

US Dermatology Resident Responses about the COVID-19 Pandemic: Results from a Nationwide Survey

Yumeng M. Li, MD, MS, Fabrizio Galimberti, MD, PhD, Michael Abrouk, MD, Robert S. Kirsner, MD, PhD

Psychiatric Morbidities among COVID-19 Survivors

Lalasa Doppalapudi, MD, Steven Lippmann, MD

Posted in: SMJ

Aspects of COVID-19 featured in the Southern Medical Journal

September 8, 2020 // Randy Glick

We in the United States have been living—and, unfortunately, dying—with COVID-19 for ¾ of a year, most acutely during the last 6 months, since the pandemic was declared. Almost everything about our lives has changed radically because of a virus we can’t see. But we can see its effects: nearly 200,000 dead (widely acknowledged to be an undercount of the true toll), millions of cases, millions unemployed (and many won’t return to the job they held before COVID because it no longer exists), businesses closed permanently, mandatory mask wearing in many public spaces, social distancing and social fears/suspicion, schools delaying or canceling in-person teaching, families struggling with childcare, people affected by isolation and depression, and on and on. 

Our frontline warriors and heroes—healthcare workers—see and feel these effects up close in long, stressful workdays, and they’re being affected, too. The September issue of the Southern Medical Journal looks at a few aspects.

One aspect is how COVID-19 is affecting medical resident training. This may not seem like it impacts consumers, but think about your last visit to the ER—you or your child were likely treated by a resident. Residents’ health, physical and mental, have an effect on how patients get treated. 

Researchers at the University of Miami did a nationwide survey of dermatology residents, some of whom have been reassigned to treating patients with COVID. Some said they felt uncomfortable about treating patients with the virus, because it’s not their area of expertise. Of those reassigned, less than half were comfortable with their new duties. And they’re very worried about the long-term effects of the virus on the economy and their job prospects after graduation, which is a concern many of us share about our own lives. 

There was a bright spot from the survey, which was that the residents are becoming more comfortable with and good at using telemedicine. (Another article in this issue notes that “telemedicine is a viable way to deliver health care,” a brand of medicine that has been slow to catch on.) This is especially welcome news for people who don’t have easy access to a doctor but do have a cell phone or computer, including people living in more rural and medically underserved areas of the country. And technology is helping residents learn, as more classes move exclusively online, to help prevent the spread of the virus. The jury is still out on whether they learn better from online instruction than from in-person teaching, however.

Those who have tracked the spread of COVID-19 around the world believe that international travel, especially from Europe, is responsible for COVID coming to our shores. Something that may have identified transmission of the virus in the US earlier is physicians and healthcare workers’ asking patients for travel histories—where have you traveled recently and were you or are you now sick?—as part of the examination. The percentage of doctors and medical residents asking for travel histories is quite low; almost 50% of residents have no training at all in obtaining travel histories, and if they do have training, they are more comfortable diagnosing/treating conditions from US domestic travel than from international travel. The situation is even worse in treating children, with children being more susceptible to travel-related illness than their parents and misdiagnosis frequent (eg, a study found that malaria in children was more likely to be misdiagnosed as something more like inflamed intestines/diarrhea). This can have serious implications for public health, as children because of their immature immune systems and undeveloped hygiene practices tend to spread infection among their friends and then to parents and to the public at large. This article by Stacy Gaither and colleagues is an eye-opener and definitely a reminder that we must advocate for our well-being and that of our children with our healthcare providers.

Turning from those on the frontline of treatment, the Journal speaks to COVID-19’s effects on consumers/patients in 2 articles geared toward the future with the virus. Two researchers in psychiatry from Kentucky and Oklahoma report that some of the effects coming directly from the infection itself are psychological. Almost half of the survivors of the 2003 SARS outbreak (SARS is a coronavirus, just like COVID) have been found to have anxiety and/or insomnia long after they recovered from the virus. Other symptoms that persisted were depressed mood, PTSD, OCD, panic disorder, memory impairment, fatigue, and/or irritability. Right now, it is unclear whether COVID-19 will have the same psychological and neurological legacy as the 2003 SARS pandemic, but studies are pointing in that direction.

The other article is extremely timely, as we count down the days to the 2020 election and the many controversies surrounding voting. Can we vote in person? Should we vote in person? What about voting by mail? What precautions are going to be taken by the government to make voting in person safe? This is not just about our individual futures but also about the future of our country, both futures that will be different from what we might have expected because of something we cannot see.

About the Author
Anita McCabe is socially distancing with a small collection of color-coordinated and medically effective face masks in Austin, TX. She has been writing about science and medicine and editing books and journals on those topics since the age of the dinosaurs (well, OK, it was the 1980s). Her areas of interest are pathology and infectious diseases, but COVID was still an unwelcome surprise.

References and Resources

A Mesothelioma Cancer Survivor Story

August 19, 2020 // Randy Glick

Today, I try not to live in fear and constantly remind myself how precious each day is. Watching my wife fight for her life after being diagnosed with mesothelioma cancer, I know to never take anything for granted. That’s because this disease is so deadly – around 3,000 people are diagnosed each year, and very few live beyond a year.

Now imagine, just three months after celebrating parenthood with a sweet innocent baby girl, you find out that your wife has been diagnosed with malignant pleural mesothelioma. What’s going to happen to my wife? Where can I find help? What is this cancer? What about Lily? These are just some of the questions that immediately ran through my mind.

Now, ten years later, my wife is cancer free! She beat the odds! I will never forget all the pain, and suffering she went through. Rare cancers like Mesothelioma need attention. Here’s a quick video of our story:

Mesothelioma is a rare, but preventable, cancer. It’s only known cause is from exposure to asbestos. For asbestos to be a threat, it needs to disturbed or broken. The tiny particles can easily be inhaled and become trapped in the lungs.

There are three main types of mesothelioma: pleural (develops in the lining of the lungs), peritoneal (develops in the lining of the abdomen), and pericardial (develops in the lining of the heart).

Since the symptoms of mesothelioma are similar to other illnesses – such as lung cancer – it is very hard to diagnose, and it can take decades for the symptoms to even begin appearing. On average, most people who are diagnosed are between the ages of 50 and 70. Each year about 3,000 people are diagnosed, and unfortunately are given on average of 10 to 21 months to live. Although there isn’t a cure for mesothelioma, there are some promising treatments that can help extend the lives of those affected...

Mesothelioma Awareness Day is an annual observance started by the Mesothelioma Applied Research Foundation. The day sheds light on mesothelioma in the hopes of increasing funding to find a cure.

If you would like to get involved with the Mesothelioma Awareness Day efforts please check out:

Mesothelioma Cancer Alliance

Mesothelioma Applied Research Foundation

TLC-Childhood Cancer Survivorship Program

August 19, 2020 // Randy Glick

In recognition of September being Childhood Cancer Awareness Month, SMA revisits the 2013 interview with Dr. Kimberly Whelan who discussed the Taking on Life After Cancer (TLC)  Childhood Cancer Survivorship Program at Children’s of Alabama, the only multidisciplinary clinic in Alabama specifically for survivors of childhood cancer.

As survival rates for childhood cancer continue to rise and the outlook for survivors continually improves, there is now increased interest in, and emphasis on, the risks and complications related to survivors’ diagnosis and treatment. SMA had the opportunity to speak with Kimberly Whelan, MD, MSPH, Associate Professor of Pediatrics at the University of Alabama at Birmingham (UAB) and Director of  the Taking on Life After Cancer (TLC)  Childhood Cancer Survivorship Program at Children’s of Alabama the only multidisciplinary clinic in Alabama specifically for survivors of childhood cancer.

About the TLC-Childhood Cancer Survivorship Program
Established in 2004, the TLC program focuses on the needs of cancer survivors and helps educate them, as well as their families, regarding the aspects of the patient’s diagnosis and treatment. “We share with them the things that, at this time, we know they might be at risk for, which could be anything from fertility and cardiac complications to secondary cancers, and to really empower them to be advocates for themselves,” Dr. Whelan explained.

Treating survivors who are at least two years off treatment, the clinic has seen patients ranging in age from 4-49 years.  The TLC program strives to help survivors lead successful lives by informing them and their families about their diagnosis and therapy; educating them about long-term effects of cancer treatment; screening for late effects; offering psychosocial support; and providing referrals to appropriate specialists when necessary. In meeting the needs of those they serve, the clinic staff are mindful of the relationships between the survivors and their physicians. “We don’t want to take over the role of the primary oncologist; they have a special bond with the family and with their patients.” Dr. Whelan said. “In a lot of cases, it’s really meant to be an educational and risk-based screening visit to let the family and survivor know the things that they need to be looking out for.”

With evidence indicating the potential for significant risks and complications associated with a patient’s diagnosis and treatment that can continue several decades beyond their initial cancer treatment, Dr. Whelan noted that a majority of childhood cancer survivors will likely develop a chronic disease by the age of 40 and of those, 25% could have a serious or life-threatening chronic medical condition, thus making follow-up treatment and care of utmost importance. “Many survivors may deal with multiple health conditions related to their diagnosis and treatment and that risk does not seem to plateau,” she said. “The risk for developing chronic conditions related to their treatment continues to increase as the survivors age.” Dr. Whelan further explained that risks are dependent on several things, including the age of the child at diagnosis, his underlying cancer diagnosis, and the types of treatment he received. She also indicated that certain therapies may yield greater risks and that  some patients, such as brain tumor survivors, bone marrow transplant survivors, or some sarcoma survivors who were treated with more intensive therapies,  are more at risk for having late complications of their treatment.

The majority of patients are referred to the program  by their primary oncologist and the goal of the TLC program is for 100% of survivors to come for at least one clinic visit during which they receive a treatment summary that details their original diagnosis, known complications related to their cancer, surgeries they had, and the chemotherapy protocol and drugs that were used. “With drugs such as anthracycline agents, knowing the cumulative dose the patient received is very important in determining his risks for certain complications like cardiac dysfunction and how often he needs to be screened,” Dr. Whelan explained. Because communication among the medical team is key, survivors are not the only ones who receive the copies of the summary information. “We provide a copy to their primary care physicians because that’s where the majority of these survivors are being followed decades down the road,” Dr. Whelan said. “We want to let them know the details of the treatment and things that they may need to be aware of and screening for.”

Years of Progress
Dr. Whelan, who was in fellowship training at UAB when the clinic first opened, has witnessed its evolution over the past nine years. “There have been a lot of advances in the way that we treat children with cancer, particularly in trying to move toward more focused or targeted therapies that may potentially be less toxic down the road than our older chemotherapy agents,” she said.  As with any new treatment regimen, Dr. Whelan acknowledges these therapies will require monitoring. “We do not yet have a lot of that long-term information and data to know what we will need to be aware of in regards to late effects.”

Therapy and treatment protocols are not the only things to have evolved since the program’s  beginning. “Over the past decade there has been an increasing awareness among medical providers, the families, and the survivors themselves of the impact their cancer treatment could have on their current or their future health,” Dr. Whelan said. “We have certainly seen an increase in willingness from our pediatric oncologists to refer patients to come see us and receive [education] and risk-based screening.” Physicians, however, are not the only ones who can make referrals to the clinic. Survivors and their families also call or self-refer to the clinic due to problems they are concerned may be related to their past treatment or because they found information making them realize they needed to learn more about their treatment details.

Through her dedication to, and involvement in, the TLC program, Dr. Whelan recognizes changes that she herself has experienced. “What I’ve also come to appreciate is that when you’re talking to the family and the survivor [who is] 8 years old, you’re talking to the parents and then when [the survivor] is 18 or 20, you are having that conversation with the survivor herself,” she observed. “And what they’re concerned about at 8 years old, maybe school and neurocognitive issues, [is different] when they are 20, when they may be more concerned about future fertility.”

A Bright Future
Although much time at the TLC clinic is spent focusing on the high rate of chronic conditions, risks, and complications in survivors, Dr. Whelan said that data from the Childhood Cancer Survivors Study in which 9 out of 10 participants indicated “good” or “excellent” when asked to rate their quality of life and quality of health, have shown that the majority of survivors are doing very well. “This speaks to the fact that [many] of the late effects or complications that may occur are things that can be well managed and it also speaks to the real resiliency of this population as a whole,” she said. “There are so many survivors out there who are living their lives to the fullest and having a lot of success at it and they inspire me every day.”

Other articles in the Focus on Childhood Cancer Series:
In recognition of Childhood Cancer Awareness Month

SMJ : August 2020 Vol. 113, No. 08

August 4, 2020 // Randy Glick

The Southern Medical Journal(SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists, including medicine; surgery; women’s and children’s health; mental health; emergency and disaster medicine; public health and environmental medicine; bioethics and medical education; and quality health care, patient safety, and best practices.

Responding to COVID-19: Perspectives on Curricular Changes in a Rural Medical School

Loni Crumb, PhD, LCMHCS, Kendall M. Campbell, MD, Allison Crowe, PhD, LCMHCS, Janeé Avent Harris, PhD, LCMHCA, Cassandra Acheampong, PhD, LCMHC, Janae Little, MS

Narrative Medicine Rounds: Promoting Student Well-Being during the Third Year of Medical School

Sarah E. Stumbar, MD, MPH, Adriana Bracho, MPH, Gregory Schneider, MD, Marquita Samuels, MBA, Marin Gillis, PhD

Exploring Knowledge, Beliefs, and Attitudes about Teen Pregnancy among Latino Parents in Arkansas

Alexandra Bader, MD, MSGH, Kristie Hadden, PhD, Micah Hester, PhD, Jennifer Gan, MBA

Patient and Hospital Characteristics of Newborns with Neonatal Withdrawal Syndrome

Brook T. Alemu, PhD, MPH, Olaniyi Olayinka, MD, MPH, Beth Young, MSW, LCSW, LCAS, Dolly Pressley-Byrd, PhD, MSN, Tyler Tate, BS, Hind A. Beydoun, PhD, MPH

Presentation with Anosmia and Ageusia: Possible Hidden Carriers of COVID-19

Elham Iran-Pour, MD, Amir Ali Tavabi, MD, Ali Seifi, MD

Association of Renal Clearance with Cerebral White Matter Vascular Disease in Hospitalized Veterans With and Without Delirium

Mark B. Detweiler, MD, MS, Brian W. Lutgens, MSW, Devasmita Choudhury, MD, Arline Kenneth, MD, Naciye Kalafat, MD, Rathnakara M. Sherigar, MD, Geoffrey Bader, MD

Social Norms and Self-Management Ability among Uninsured Primary Care Patients

Akiko Kamimura, PhD, MSW, Rebecca Higham, BS, Samin Panahi, BS, MS, Edward Lee, BS, Jeanie Ashby MPH

Posted in: SMJ

Comparative Analysis of Chronic Diseases in the Southeastern United States vs. the United Kingdom: Focus on Cancer

July 30, 2020 // Randy Glick

This is the second in a series of comparative investigations into the prevention and management of the main chronic diseases and causes of death in the United Kingdom versus those in the Southeastern United States.

The series continues with cancer, a group of over 200 different diseases in which cells in a specific part of the body grow and reproduce uncontrollably. Cancerous cells can invade and destroy surrounding healthy tissue, including organs.

About half of the population will develop some form of cancer during their lifetime. In the UK, the four most common types of cancer are breast, lung, prostate, and bowel cancer. Together these comprise about 53% of all new cancer diagnoses in the UK.

In total, there are around 367,000 new cancer cases in the UK every year, or about 1,000 every day. More than a third of cancer cases in the UK are diagnosed in people aged 75 and over, with the highest rates for all cancers in people aged 85 years and above.

In terms of mortality from cancer in the UK, there are around 165,000 cancer deaths per year, or around 450 every day, accounting for 28% of all deaths in the UK. The four main cancer types together account for 45% of all deaths from cancer in the UK. Again, rates are higher in people aged 75 and above, with the highest mortality in people aged 90 or above.

In the US, as in the UK, the top causes of cancer are breast, lung, prostate, and bowel cancer. In terms of mortality, lung cancer poses the highest risk, followed by breast, prostate and bowel cancer.

About 1,700,000 new cases of cancer are diagnosed in the US annually, and there are about 600,000 deaths from cancer, about 1,640 per day. This accounts for one in every four deaths in the US, a similar rate to the UK.

Cancer rates are measured for each state by the Centers for Disease Control and Prevention. The highest rate for cancer overall is seen in Kentucky, both in number of diagnoses and number of deaths. 10,135 people died of cancer in 2018 in the state, the last year of record. That comes out to 181.6 deaths per 100,000 people per year being caused by cancer.

The four next highest rates - all of those with more than 170 deaths per 100,000 people - are also in the Southeastern states.  The state of Mississippi follows up Kentucky with a mortality rate of 179.7. Next is West Virginia with 179.5, then Oklahoma at 178.1, and Alabama with 170.4.

Below these, the states with the next three highest cancer mortality are also in the Southeast: Louisiana, Arkansas and Tennessee.

Cancer prevention in the UK is largely focused on giving the public advice and support on how to reduce risk factors: quit smoking, reduce alcohol, stay safe in the sun, improve diet, exercise more and keep within a healthy body mass index. This information is provided by initiatives from the Government’s Department of Health as well as several cancer charities. 

The largest cancer-related charity, Cancer Research UK, is a household name and funds a very wide range of research every year. Their leaflets are a common sight at many healthcare providers, both within the National Health Service and the much smaller private healthcare sector.

The NHS gives universal health coverage free at the point of use, funded via taxation. Its Long Term Plan, created in 2019, aims for 55,000 more people every year to reach five-year survival by 2028. It also aims to diagnose 75% of people with cancer at an early stage (stage one or two) by 2028.

In order to reach these aims, more investment is being made in the NHS national screening programmes. These include cervical screening at 3-5 year intervals for women aged 25 to 64, breast screening for women aged 50 to 70, and bowel cancer screening for men and women aged 60 to 74. There is no national screening programme for lung cancer in the UK.

Screening programmes are overseen by separate organisations in each of the four nations of the UK. These are Public Health England, Public Health Wales, Public Health Scotland, and Northern Ireland’s Public Health Agency.

Local primary care providers called general practitioners administrate these services from their practices. If possible cancer symptoms are found, the patient is referred by their general practitioner to an oncology consultant who is based at a nearby hospital. The consultant will carry out clinical Investigations, leading to a diagnosis and treatment when necessary. Alternatively a patient might attend a hospital’s accident and emergency department with symptoms that require urgent assessment. 

Once diagnosed, cancer treatment in the UK - most often surgery, chemotherapy and/or radiation therapy - is also usually provided by the NHS. Patients can access cancer treatment from private providers which charge fees, but usually treatments for cancer are the same under both systems. Some tests or treatments can be done more quickly in private practice, with shorter waiting lists. But some cancer treatments which specialised equipment, such as radiotherapy, may not be available in private hospitals.

The NHS sets out detailed standard treatment pathways for each type of cancer. It also sets a range of performance targets, for example, a maximum two week wait before being seen by a specialist after urgent referral for suspected cancer by their GP. In 2018-19, this target was met in 92% of cases.

In addition, 97% of NHS patients began cancer treatment within 31 days of diagnosis. One further national target is a maximum delay of 62 days for treatment following referral from an NHS cancer screening service. This rate was 88% in 2018-19.

In the US, the Centres for Disease Control and Prevention encourages cancer prevention by providing support and prevention over a lifetime. It gives advice on how to completely or partially avoid the modifiable risk factors, for example, avoiding or quitting smoking, not drinking or limiting alcohol intake, and using sun protection.

The CDC encourages screening for breast, cervical, colorectal, and lung cancers as recommended by the US Preventive Services Task Force. It suggests that women who are 50 to 74 years old get a mammogram every two years, and a pap smear test every three years from age 30 to 65. Some women will be eligible for free or low-cost mammograms under the CDC’s National Breast and Cervical Cancer Early Detection Program. 

The CDC also recommends regular screening for colorectal cancer from 50 to 75 years, and yearly lung cancer screening for current or former smokers aged 55 to 80 years. In addition, HPV vaccination is recommended for preteens aged 11 to 12 years.

The National Cancer Institute - the federal government's main agency for cancer research - released its latest Annual Report to the Nation on the Status of Cancer on March 12, 2020. It explains that deaths from cancer continue to decrease in men, women and children, and their ‘Healthy People 2020’ targets were met for lung, prostate, breast, and colorectal cancer mortality.

Unfortunately, national improvements in the cancer statistics have not reached the individual states equally. The southeastern states continue to show higher than average rates of cancer diagnoses and mortality. Where healthcare is geographically accessible in very rural states such as Texas, barriers related to care can still exist. Such barriers often relate to finances, transportation, cultural and language differences, lack of insurance and family support.

However, state-level comprehensive cancer control plans created by the CDC are in place, and renewed every five years. These “blueprints for action” identify how the burden of cancer in each geographic area can be addressed in ways specific to each region.

Much remains to be accomplished, but in the United States overall, cancer rates are declining nationally for the first time in history, as a result of risk reduction, education, early detection advances, and novel treatments based on good quality research.

About the Author

Jane Collingwood is a medical journalist with 17 years experience reporting on all areas of medical research for online and print publications. Jane has also worked on a range of medical studies funded by the UK National Health Service within the University of Bristol in the South West of England. Jane has an academic background in psychology and has authored books on stress management and respiratory infections. Currently she is combining journalism with a national coordinating role on the UK's largest surgical research trial.

SMA Welcomes Betsy Schaaf, J.D. to SMA Services, Inc.

July 7, 2020 // Randy Glick

We are pleased to announce that Betsy Schaaf has accepted the position of Director of Compliance Services, effective July 7, 2020. Betsy is an ERISA attorney bringing over 20 years experience in ERISA Compliance, including retirement plan administration and customer service. She is a proven leader with significant experience aligning teams across locations, document drafting and system conversions. She has served as an ERISA subject matter expert for multiple financial institutions and offered ERISA training to a variety of audiences.

She lives in Loveland, Ohio (a suburb of Cincinnati) with her husband Andy, daughter Katy (17), son Will (15) and our black lab “Putnam”. Her hobbies include reading, taking walks with her family, spending time at the pool and on the golf course.  Her family loves college basketball (Xavier University season ticket holders for 20+ years.). They are also a big Disney family and frequently travel to Disney World. They also enjoy visiting her husband's family in Wisconsin.

Relevant Experience

  • As an ERISA consultant, Betsy identified and engaged a solution for the client’s Automatic IRAs and lost and missing participants
  • As an independent consultant with a National Insurance Company, Betsy served as a subject matter expert for the implementation of DOL Fiduciary regulation across all product lines, successfully utilizing an Agile approach. Although the Rule was eventually overturned, the client was well-positioned to fully implement the recommended courses of action in advance of the effective date of the Rule
  • Betsy has led teams through multiple document restatements, with a focus on plan improvement and client satisfaction. All of these projects were completed on time and under budget
  • She has served as a leader during system conversions at two major insurance companies
  • Betsy has fostered and maintained relationships throughout the Retirement Plan Industry, cultivating a strong network of associates with valuable expertise

Specialities

ERISA expertise, Plan design, Customer service, Agile Project Management, Leadership, Change Management, Service Optimization

Prior Positions Held

  • DOL Fiduciary and Compliance Consultant – Ohio National Financial Services
  • ERISA and Retirement Plan Project Consultant – Ohio National Financial Services
  • Vice President, ERISA Plan Services – Ameritas Life Insurance Corp.
  • Vice President, ERISA Plan Services & Administration – Ameritas Life Insurance Corp.
  • Vice President, ERISA Plan Services – Union Central Life
  • Former Board Member – The SPARK Institute

SMJ : July 2020 Vol. 113, No. 07

July 6, 2020 // Randy Glick

The Southern Medical Journal(SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists, including medicine; surgery; women’s and children’s health; mental health; emergency and disaster medicine; public health and environmental medicine; bioethics and medical education; and quality health care, patient safety, and best practices.

Reflections on the Hippocratic Oath and Declaration of Geneva in Light of the COVID-19 Pandemic

Satyaseelan Packianathan, MD, Srinivasan Vijayakumar, MD, Paul Russell Roberts, MD, Maurice King, MD

Impact of Do-Not-Resuscitate Orders on Nursing Clinical Decision Making

Rebecca Engels, MD, MPH, Casey Graziani, MD, Ixavier Higgins, BS, Jessica Thompson, NP, Roberta Kaplow, PhD, APRN-CCNS, Theresa E. Vettese, MD, Annie Massart, MD

The Minority Doctors We Create

Kendall M. Campbell, MD, Michaela M. Braxton, BSW

Who’s Flying the Plane?

Paul L. Friedlander, MD, David J. Doukas, MD, Marc J. Kahn, MD, MBA

Salary Disparities in Academic Urogynecology: Despite Increased Transparency, Men Still Earn More Than Women

William D. Winkelman, MD, Andrea Jaresova, MD, Michele R. Hacker, ScD, Monica L. Richardson, MD, MPH

Increased Prevalence in Alzheimer Disease in the Northeast Tennessee Region of the United States

Sylvester O. Orimaye, PhD, MPH, Jodi L. Southerland, DrPh, Adekunle O. Oke, MD, MPH, Aderonke Ajibade, MD, MPH

Primary Care Perceptions and Practices on Discussion and Advice Regarding Sexual Practices

George G.A. Pujalte, MD, Isaac I. Effiong, MD, MPH, Livia Yumi Maruoka Nishi, MD, Adrianna D.M. Clapp, MD, Thomas A. Waller, MD

Posted in: SMJ

Jeremy Schubert

June 11, 2020 // Randy Glick

Divisional Vice President, USO Commercial Operations
Abbott Diagnostics Division
Conway Park, IL, USA

jeremy.schubert@abbott.com
(224) 399-5317

Jeremy has dedicated his entire professional career to Abbott joining in 1993.  He has held several commercial and leadership positions across multiple divisions of Abbott, including Managing Director for Northern Europe and Divisional Vice President of Latin America and Canada.  Jeremy assumed his current role as Divisional Vice President for US ADD Commercial Operations in 2017.

Jeremy attended Texas A&M University where he received a degree in International Marketing.  Jeremy is a member of the International Health Economic Association and earned an MBA from The Kellogg School of Management with an emphasis in strategy, marketing, and healthcare economics.

Jeremy also possess a Master’s in Public Health (MPH) from the University of Liverpool in the UK with expertise in health system performance improvement, social determinants, and building healthier communities.

Posted in: Hidden

John Hackett, Ph.D

June 11, 2020 // Randy Glick

John Hackett is divisional vice president of Applied Research and Technology for Abbott's diagnostics business. In this role, he manages diagnostics R&D in the areas of infectious diseases, oncology, cardiovascular, metabolic biologics design and discovery, and clinical chemistry.

John is responsible for managing Abbott’s Global Viral Surveillance Program, which was established more than two decades ago to detect and actively monitor emerging HIV and hepatitis strains around the world. The Surveillance Program houses more than 78,000 samples containing HIV and hepatitis viruses, making it one of the largest libraries in the world. If a new strain is discovered, Abbott’s scientists check that the current blood screening and diagnostic tests can detect it.

John also manages a multi-year collaboration between Abbott and the University of California San Francisco (UCSF), the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC). The VDDC uses deep sequencing and ultra-rapid pathogen identification technologies to identify and characterize novel human viruses – to help safeguard public health against these potential threats.

John joined Abbott in 1992 and has more than 125 patents and publications to his name, having spent his career helping to keep Abbott one step ahead of these evolving viruses. He joined Abbott in 1992, was inducted into Abbott's Volwiler Society as an Associate Research Fellow in 1999, promoted to Research Fellow in 2005, and Senior Research Fellow in 2012.

He received his Ph.D. in immunology from the University of Texas Southwestern Medical Center at Dallas and completed his postdoctoral training at the University of Chicago.

John is a member of the International Society of Blood Transfusion, Industry Liaison Forum for the International AIDS Society, and serves on the Executive Council of the Autumn Immunology Conference.

 

Posted in: Hidden

Comparative Analysis of Chronic Diseases in the Southeastern United States vs. the United Kingdom: Focus on Cardiovascular Disease

June 11, 2020 // Randy Glick

This is the first in a series of comparative investigations into the prevention and management of the top chronic diseases and causes of death in the United Kingdom versus those in the Southeastern United States. It will cover primary and secondary prevention, pharmacological management, lifestyle factors, patient education, access to care, and outcomes. 

The series begins with cardiovascular disease, or CVD, which is a general term for conditions affecting the heart or blood vessels. It's usually associated with a build-up of fatty deposits inside the arteries (atherosclerosis) and an increased risk of blood clots, but can also be linked with damage to arteries in organs such as the brain, heart, kidneys and eyes.

The four main types of CVD are: coronary heart disease and resulting heart attack or heart failure; stroke and transient ischaemic attack; peripheral arterial disease; and aortic disease. 

Risk factors include high blood pressure, atrial fibrillation, high cholesterol, diabetes, smoking, inactivity, and being overweight or obese, family history of CVD, and certain ethnic backgrounds. Additional risk factors are older age, being male, unhealthy diet, and excessive alcohol.

In the UK, there are around 7.4 million people living with CVD: 3.9 million men and 3.5 million women. If high blood pressure is included, the figure reaches about 39% of adults. The condition causes about 27% of all deaths in the UK - around 167,000 deaths each year – an average of 460 deaths each day.

In the US, about 121.5 million American adults have some form of CVD, including high blood pressure - around 37% of adults. It accounts for about 860,000 deaths each year, that’s one in three deaths. The leading cause of death attributable to CVD is heart disease (42.6%), followed by stroke (17.0%), high blood pressure (10.5%), heart failure (9.4%), diseases of the arteries (2.9%), and other cardiovascular diseases (17.6%).

Some of the highest rates of cardiovascular events occur in the Southeastern region, according to a January 2020 report from the American Heart Association. Two of the three states with the highest CVD event rates (comprising deaths, hospitalizations, and ED visits) are the Southeastern states Kentucky and Tennessee. 

The AHA report says, “A region of higher CVD mortality extends from southeastern Oklahoma along the Mississippi River Valley to eastern Kentucky.” It adds that this trend seems to be driven by dietary, blood pressure, and body mass index risk factors.

However, there is a huge opportunity to make a difference in improving CVD outcomes, given that the majority of CVD cases are preventable. Patient education often targets the potentially modifiable risk factors: diet, physical inactivity, smoking and drinking at unsafe levels.

Primary prevention strategies in the UK are coordinated by the government’s Department of Health, which creates salt, sugar and calorie reduction targets, some of which are enforced by legislation such as the Soft Drinks Industry Levy, or “sugar tax”, and high tobacco taxes.

All UK residents can access care from the National Health Service, both primary and secondary care. People with CVD symptoms will either visit their General Practitioner at a local NHS clinic, who may refer them to a consultant at a nearby hospital. Or if the symptoms need urgent treatment, the patient will be taken by ambulance to the emergency department of the nearest hospital. There are over 157,000 hospital visits each year due to heart attack alone.

Guidelines set out by the UK’s National Institute for Health and Care Excellence outline best practice prevention and management of CVD in the UK. These guidelines are designed to help primary care providers - General Practitioners - to identify those who are at high risk. They outline lifestyle behaviours and treatment options that can help reduce the onset of CVD or help manage it if already developed.

The latest guidelines advise that people aged over 40 years should have their estimate of CVD risk reviewed on an ongoing basis, at least every five years. Pharmaceutical treatment is recommended if an individual has a greater than 10% risk of developing CVD, measured with the “QRISK” assessment tool, an algorithm that calculates 10-year risk of developing CVD. 

The recommended therapy is 20mg atorvastatin (Lipitor) per day to lower blood lipids, if there are no contraindications.

People with established CVD are at high cardiovascular risk and need intensive lifestyle interventions and ongoing drug therapy. This group includes people with angina pectoris, coronary heart disease, myocardial infarction, transient ischaemic attacks, cerebrovascular disease or peripheral vascular disease, and those who have had coronary revascularization or carotid endarterectomy.

Following a full lipid profile measurement, the drug treatment currently recommended in the UK is lipid modification therapies, starting with the statin atorvastatin at 80mg per day, if appropriate for the patient.

The goal is a greater than 40% reduction in the patient’s non‑HDL cholesterol after three months of treatment. If this is not achieved, adherence to the drug and lifestyle improvements are discussed, and the patient is reviewed again on a regular basis.

In the US, the American College of Cardiology and the American Heart Association Task Force issued clinical practice guidelines in 2019 on the primary prevention of CVD. They write, “The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life.” 

In addition, they recommend that evaluation for CVD risk should include an atherosclerotic cardiovascular disease (ASCVD) risk estimation, which provides measures of 10-year and lifetime risk based on factors such as age, blood pressure and cholesterol.

The ASCVD estimator has many similarities to the UK’s QRISK tool, however the QRISK includes socioeconomic data, but lacks the ASCVD’s lifetime risk calculation. ASCVD is often used instead of the previously-recommended Framingham Risk 10-year CVD calculation.

Patients are considered to be at "elevated" risk if the ASCVD predicted risk is 7.5% or above. The ACC/AHA guidelines recommend that. “Only when a person’s risk is sufficiently high should medications to reduce ASCVD risk be considered as part of a shared decision-making process for optimal treatment.”

When necessary, individuals with an ASCVD predicted risk of 7.5% or above, or LDL cholesterol of 190mg/dL or above, or diabetes plus an LDL of 70 to 189 mg/dL may benefit from moderate- or high-intensity statin therapy.

As with the UK, atorvastatin at up to 80mg per day is recommended as a first-line treatment, or alternatively, rosuvastatin (Crestor) at up to 40mg per day. Following pharmacological therapy, the target blood pressure is 130/80 mm/Hg. Again, this is the same target as that set in the UK.

The ACC/AHA guidelines state that cholesterol-lowering or antihypertensive medication can be used in intermediate-risk individuals, when deemed suitable by the physician and patient.

They add, “The clinician must balance an understanding of a patient’s estimated ASCVD risk with potential benefits and adverse risk from pharmacological therapy.” 

Both the prevalence and cost of CVD are expected to increase over the coming decades due to an aging population and projected increases in obesity and diabetes. Health care providers in both the UK and the US are placing a strong emphasis on prevention, with public health efforts, including policy measures, to limit risk factors in order to decrease the likelihood of CVD morbidity and mortality later in life.

About the Author

Jane Collingwood is a medical journalist with 17 years experience reporting on all areas of medical research for online and print publications. Jane has also worked on a range of medical studies funded by the UK National Health Service within the University of Bristol in the South West of England. Jane has an academic background in psychology and has authored books on stress management and respiratory infections. Currently she is combining journalism with a national coordinating role on the UK's largest surgical research trial.

Posted in: Public Health & Environmental Medicine

Meet Bennet Omalu, MD, MBA, MPH, CPE, DABP-AP,CP,FP,NP

June 8, 2020 // Randy Glick

Bennet Omalu is a Nigerian born physician who holds eight degrees and certifications in the medical sciences and business management. He attended medical school and holds a Doctor of Medicine [MB,BS] degree from the University of Nigeria, Enugu from where he graduated in 1990. He holds a Masters in Business Administration degree from the Tepper School of Business, Carnegie Mellon University, Pittsburgh, Pennsylvania. He also holds a Masters in Public Health degree in Epidemiology from the Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. Dr. Omalu holds four board-certifications from the American Board of Pathology in four subspecialties of medicine including forensic pathology, neuropathology, clinical pathology and anatomic pathology. He is also holds a board certification in medical management from the American Association of Physician Leadership and is a Certified Physician Executive.

Dr. Omalu has received three honorary PhD and Doctor of Science degrees from two universities in the United States, and from the Royal College of Surgeons of Ireland in recognition of his work and expertise in brain injury and trauma. He has received numerous awards from across the world in recognition for his work and expertise in brain injury and trauma in both living and deceased patients. Dr. Omalu has received the “Distinguished Service Award” from the American Medical Association [AMA], which is the highest and most prestigious award a physician can receive from the AMA. He has been honored by the United States Congress for his work on brain injury and trauma and he has appeared on multiple occasions before committees of the United States Congress and committees of State Legislatures across the United States advising them on matters relating to brain injury and trauma, death investigation and the administration of justice.

Dr. Omalu identified and described Chronic Traumatic Encephalopathy [CTE] in a retired football player, when he performed an autopsy and examined the brain of Mike Webster. Subsequently, he identified CTE in other high-impact, high-contact sports athletes and in military veterans suffering from Post-Traumatic Stress Disorder [PTSD]. His work and life have been featured extensively in all media platforms across the world, and in a major Hollywood film, “Concussion” released in December 2015 by Sony Motion Pictures, in which the renowned actor, Will Smith, played him as Dr. Omalu. Several New York Times best-selling books have also been published on his life and work including “The League of Denial” and “Concussion”. He has published several books and his memoir “Truth Doesn’t Have a Side” was published in August 2017. His latest book was published in 2018 and is titled “Brain Trauma in Contact Sports: What Parents Should Know Before Letting Their Children Play”. He has published extensively in the medical and scientific literature authoring many scientific papers and book chapters, with a major focus on brain injury and brain trauma. He continues studying brain trauma and is currently collaborating with other researchers looking for ways to definitively diagnose and treat CTE in living patients.

Dr. Omalu is the President and Medical Director of Bennet Omalu Pathology and is a Clinical Professor of Medical Pathology and Laboratory Medicine at the University of California, Davis medical school. He is an appointed member of the Traumatic Brain Injury Board of the State of California. Dr. Omalu is married to his wife Prema and they have two children, Ashly and Mark. They live in Vineyard, California.

Posted in: Hidden

SMJ : June 2020 Vol. 113, No. 06

June 2, 2020 // Randy Glick

The Southern Medical Journal(SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists, including medicine; surgery; women’s and children’s health; mental health; emergency and disaster medicine; public health and environmental medicine; bioethics and medical education; and quality health care, patient safety, and best practices.

A Robust Faculty Development Program for Medical Educators: A Decade of Experience

Sarah B. Merriam, MD, MS, Rachel Vanderberg, MD, MS, Melissa A. McNeil, MD, MPH, Tanya Nikiforova, MD, MS, Carla L. Spagnoletti, MD, MS

CME Article: Relation Between Pediatric Emergency Department Activity and Patient Complexity

Barry Hahn MD, Jerel Chacko MD, Raquel Klinger , Yvonne Giunta MD

A Population-Based Study of Factors Associated with Postpartum Contraceptive Use by Birth Interval Length

Larissa R. Brunner Huber, PhD, Kenesha Smith, PhD, Wei Sha, PhD, Liang Zhao, MS, Tara Vick, MD, Tasha L. Gill, MPH

Opioid Use Among HIV-Positive Pregnant Women and the Risk for Maternal–Fetal Complications

Ngoc H. Nguyen, PharmD, Erika N. Le, PharmD, Vanessa O. Mbah, PharmD, Emily B. Welsh, PharmD, Rana Daas, BS, Kiara K. Spooner, DrPH, MPH, Jason L. Salemi, PhD, MPH, Omonike A. Olaleye, PhD, MPH, Hamisu M. Salihu, MD, PhD

Effects of Preoperative WBC Count on Post-CABG Surgery Clinical Outcome

Alexander Aizenshtein, MD, Erez Kachel, MD, Grosman Rimon Liza, PhD, Basem Hijazi, MSc, Arnon Blum, MD

Nationwide Trends in Prevalent Cardiovascular Risk Factors and Diseases in Young Adults: Differences by Sex and Race and In-Hospital Outcomes

Rupak Desai, MBBS, Upenkumar Patel, MBBS, MPH, Tarang Parekh, MBBS, MSc, Bishoy Hanna, MD, Kranthi Sitammagari, MD, Hee Kong Fong, MD, Muhammad Uzair Lodhi, MD, BSc, Yash Varma, MBBS, Nanush Damarlapally, MBBS, Rajkumar Doshi, MD, MPH, Sejal Savani, MPH, Gautam Kumar, MD, Rajesh Sachdeva, MD

Posted in: Mental HealthSMJSMJ ArticleWomen’s & Children’s Health

Physicians-in-Training Leadership Conference

May 29, 2020 // Randy Glick

Announcing - April, 2021 - Inaugural Physicians-in-Training Leadership Conference

Plans are well underway! Join us as we plan and develop our first meeting, to be held at Tulane University School of Medicine in New Orleans!

Medical Students and Residents will have an opportunity to:

  • Submit abstracts for oral and digital poster presentations;
  • Participate in hands-on workshops;
  • Network with colleagues from medical schools across SMA’s Southern Region;
  • Participate in interactive activities designed for interprofessional learning;
  • Take home practical information from keynote speakers;
  • Fulfill ACGME requirements related to participation in scholarly activities;
  • Experience one of the best meeting cities in our area - “The Big Easy”!

We are still in the initial planning stages, and NEED YOUR INPUT!

Our goal is for medical students and residents to plan and design this meeting. Please share with us:

  • Topics of interest for keynote speakers
  • Ideas for learning experiences that are unique, fun, and challenging
  • Social event ideas
  • Any ideas that would make this the PERFECT meeting to attend!

We will be launching the “Call for Abstracts” in mid-July - so NOW IS THE TIME to make your voice be heard!

The UK National Health Service: A Rural Versus Urban Perspective

May 21, 2020 // Randy Glick

Although the United Kingdom is a relatively small country, there can be a sharp contrast in living conditions between its urban and rural areas. But to what extent do health outcomes and healthcare provision vary in these different areas?

The total UK population is just under 67 million, with the population density ranging 100-fold, from 5,700 people per square kilometer in London, to fewer than 50 people per square kilometer in the most rural areas. 

For comparison, the population density for US cities tends to be lower. In Houston and Los Angeles - both roughly the same size as London - the density is about 1,400 and 2,900 per square kilometer respectively.

Rural UK areas are very diverse, ranging from open countryside with a scattering of small towns and villages to coastal communities dependent on fishing or tourism, former mining areas and commuter villages.

In both England and Scotland, about 17% of the population lives in rural areas. For Wales and Northern Ireland, the proportion is higher, at 35% and 37% respectively.

In the US, about 19% of the population overall lives in rural areas, just over 60 million people.

On average in the UK, people living in predominantly rural areas have a two-year longer life expectancy and rate their wellbeing as slightly higher than those in predominantly urban areas. But is this higher life satisfaction reflected in the quality of care provided by the National Health Service?

To briefly summarize the NHS: all individuals who are “ordinarily resident” in the United Kingdom are automatically entitled to NHS care, largely free at the point of use. Primary care is provided by a General Practitioner (GP) or nurse, at a local NHS clinic. These staff offer a range of public health services, including vaccinations and check-ups, and act as gatekeepers to secondary care services such as specialists at regional hospitals. About 11% of the population prefer to see private healthcare providers, but all emergency care is provided by the NHS.

About a tenth of the UK’s GDP is spent on the NHS. The majority of this funding comes from taxation, with separate grants given to England and each of the three devolved nations. Each country is free to decide how much to spend on their health service and each has chosen a different structure. A common theme across all is the allocation of most of the budget to local organisations, called Clinical Commissioning Groups or Health Boards, which are responsible for meeting local needs.

In terms of access to primary care, 94% of those in urban areas of England live within a 20-minute walk of a GP premises, but only 19% of those in rural areas. More accessible however, are community pharmacies, which are delivering an increasingly wide range of healthcare services to their nearby populations.

The situation in the remote and sparsely-populated Scottish Highlands was explored in a survey of 3,000 adults. Among those who needed medicine regularly, access was considered good, with 89% reporting that access to their source of medication - whether GP or pharmacy - was convenient for them. However there were issues for those over 80 years of age and living alone, but their barriers to accessing healthcare did not appear to be due to proximity to their source of medication.

An analysis of the state of care in general practice in England in 2017, found a higher proportion of ‘outstanding’ general practices in rural areas and a higher proportion of ‘inadequate’ and ‘requires improvement’ general practices in urban areas. In addition, people in urban areas are more likely to report health conditions linked to air pollution and overcrowding. 

The report is published by the Care Quality Commission, the independent regulator of health care in England. They write, “We found examples of practices that have responded well to the challenges of having a low population density in a very rural area and have adapted their practices to meet people’s needs. But similarly, in good and outstanding practices in urban areas, we have found the reasons for higher ratings may be down to how they address local challenges.”

One example of outstanding care in a small rural practice in Cumbria, North West England. They report, “The surgery was embedded in and was an essential part of the local community. Arrangements had been made to carry out joint home visits with district nurses and carers. This provided patients with a more coordinated care service. 

“The practice offered a range of compassionate services to address social isolation among its patient population. Many people lived outside the village in very rural areas, for example on isolated farms. Some of the patients had been reluctant to engage with healthcare services in the past. The GPs had overcome this and spent time getting to know these patients.”

Nevertheless, the professional body for GPs in the UK, the Royal College of General Practitioners, explains that there are specific challenges facing general practice and their patients in remote and rural areas. GP practices in remote and rural areas often report difficulties in recruiting enough GPs and practice staff needed to meet the rise in patient demand.

Longer distances to GPs, dentists, hospitals and other health facilities mean that rural residents can experience “distance decay” where service use decreases with increasing distance. Different models of service delivery may be needed for rural areas, for example, working in federations of practices to pool resources, and more services provided on and through the internet. 

A number of technological initiatives have been employed to support healthcare delivery for people in rural settings. Telemedicine is often a more convenient, accessible and cost-effective method of providing care for patients, especially those with long term conditions. These services can transform the way in which people can engage in and control their own healthcare.

The NHS’s Long Term Plan, set out in 2019, aims for digitally-enabled primary and outpatient care to go mainstream across the NHS. It states, “Digital technology will provide convenient ways for patients to access advice and care. Building on progress already made on digitising appointments and prescriptions, a digital NHS ‘front door’ through the NHS App will provide advice, check symptoms and connect people with healthcare professionals – including through telephone and video consultations. 

“Patients will be able to access virtual services alongside face-to-face services via a computer or smart phone. We will continue to invest in the nhs.uk platform so that everyone can find helpful advice and information regarding their conditions.”

The plan adds that, as technology advances, innovative devices such as smart inhalers and monitors will be trialled. Already, some GPs and nurses are now offering patients the choice of quick telephone or online consultations, saving time waiting and traveling.

GP surgeries usually have nurse practitioners who work alongside the doctors. This group of healthcare staff have had additional medical training in order to provide advanced nursing care and prescribe medication. Their main areas of expertise are in the management of common illnesses and long term conditions. Patients often see a nurse practitioner for complaints such as back pain, joint sprains, conjunctivitis, earache, tonsillitis, sore throat, minor wounds, colds and flu-like illnesses. 

A team of advanced nurse practitioners caring for isolated communities in Scotland were featured in the magazine Nursing in Practice last year. In that region of the UK care settings vary from GP practices and patient homes to enhanced community hospitals and urgent care centers. 

Lead nurse, Catherine Shaw, heads a Rural Support Team covering a population of just over 80,000 in the north and west Highlands, where recruitment and retention are a struggle. 

“In the Highlands, it’s always difficult. But everyone, wherever they are from, is equally invested. You need to be courageous but also sensible to work here. It’s a phenomenally difficult, responsible role to fill. Advanced nurse practitioners might think, ‘I do that already’, but until you do it in a very remote, rural situation, where getting support could take hours, I don’t think it hits home just how much responsibility you have.

“Some of those little communities are hours away from the nearest hospital. With the introduction of the advanced nurse practitioners, we’re now more about keeping people at home, if we can. It may be that previously they would have been taken to hospital, which could be three or four hours away.”

In both rural and urban areas, nurses working at GP surgeries carry out routine wellness checkups. The NHS offers standard health checks for everyone aged 40 to 74, without a serious condition, every five years. It focuses on vascular and circulatory health, and is designed to identify early signs of stroke, kidney disease, heart disease, type 2 diabetes or dementia.

In rural areas, despite greater remoteness from GP surgeries, this initiative can still reach large numbers of the population when GP practices and pharmacies work together to provide the checks, sometimes via local employers, mobile units, or providing them at non-medical locations in the area. Over a million individuals in the UK undertake this checkup every year, and uptake in rural populations is comparable to urban areas due to the flexibility in access.

So does the NHS adequately meet the specific needs, culture and lifestyles of rural and urban populations? It would seem there are many examples of healthcare teams working in ways that respond to the specific needs of people living in different settings.

The NHS is successfully taking a “place-based approach to health needs”, according to a report by the Local Government Association. “The health of people in rural areas is on average better than that of urban areas with higher life expectancy and infant mortality and a lower number of potential years of life lost from cancers, coronary health disease and stroke,” it states.

“However, as the rural population is older, the prevalence of these conditions is higher. Those living in town and fringe settlement types have higher mortality rates than those living in village and dispersed areas. Overall, around one sixth of areas with the worst health and deprivation indicators are located in rural or significantly rural areas.”

Overall, there are fewer NHS staff per head in rural areas than in urban areas, and the population is older than average in rural areas, which has implications for demand for health services. Staffing constraints mean it is not possible to provide fully-staffed specialist services in all locations. Instead there is a “pyramid” of services with fully-staffed specialist services in central - generally major urban - locations.

Rural hospitals are often unavoidably small due to their remoteness, so they can have high cost pressures, as well as longer waiting times and more delayed transfers of care. These pressures on their financial position may be compounded by difficulties in staff recruitment and retention and higher overall staff costs.

There are inevitable trade-offs between the desire to offer equal access to services to everyone, and the financial costs of doing so where economies of scale cannot be achieved. However, centralized NHS funding means that although these hospitals may be in financial deficit, they are rarely closed altogether.

Commenting on the financial position of rural healthcare services, Dr Richard Parish of the National Centre for Rural Health and Care, says, “Over nine million people in the UK live in rural areas, so it is vitally important that we identify the challenges to providing health and care services for them and that we can challenge any imbalance in funding, attention or prioritisation for the benefit of our rural populations.”

Despite all the challenges facing healthcare in remote areas, studies have consistently found higher well-being scores among people in rural areas. In a 2017 study, people living in predominantly rural areas rated their wellbeing as slightly higher than those in predominantly urban areas. They were asked questions on life satisfaction, how happy and how anxious they had been recently, and how worthwhile the things they do are. The difference in ratings was small but consistent across these four measures of wellbeing. 

So it would seem that the challenges facing healthcare delivery in rural areas of the UK do not, in most cases, lead to worse outcomes, and in fact can mostly be overcome with good planning and innovation. As we have seen, rural living can lead to a better quality of life, despite the greater geographical distances between healthcare providers.

About the Author

Jane Collingwood is a medical journalist with 17 years experience reporting on all areas of medical research for online and print publications. Jane has also worked on a range of medical studies funded by the UK National Health Service within the University of Bristol in the South West of England. Jane has an academic background in psychology and has authored books on stress management and respiratory infections. Currently she is combining journalism with a national coordinating role on the UK's largest surgical research trial.

A Day in the Life of Resident: Part 1

May 18, 2020 // Randy Glick

One of SMA's resident members is on the move!

A Day in the Life Video Series: Part 1

Dr. Dantwan Smith, a PGY2 resident at Magnolia Regional Health Center in Corinth, Mississippi, discusses his daily routine, caring for COVID-19 patients, and balancing other responsibilities as resident.

He is also Co-Chair of the Physicians-in-Training Leadership Working Group.

World Hypertension Day is May 17, 2020

May 15, 2020 // Randy Glick

Uncontrolled high blood pressure is common; however, certain groups of people are more likely to have control over their high blood pressure than others.

  • A greater percent of men (47%) have high blood pressure than women (43%).
  • High blood pressure is more common in non-Hispanic black adults (54%) than in non-Hispanic white adults (46%), non-Hispanic Asian adults (39%), or Hispanic adults (36%).
  • Among those recommended to take blood pressure medication, blood pressure control is higher among non-Hispanic white adults (32%) than in non-Hispanic black adults (25%), non-Hispanic Asian adults (19%), or Hispanic adults (25%).

*Statistics provided by the CDC

Hypertension: Still a Significant Health Concern

Heart disease or cardiovascular disease continues to be the leading cause of morbidity and mortality in the United States and now globally. It is appropriate that we continue to educate clinicians and citizens of the pathophysiology, clinical consequences, and management of heart disease. Since hypertension is the leading risk factor for cardiovascular disease including its major target organs such as the heart, brain, kidney, and blood vessels, this podcast will be dedicated to hypertension. Areas of discussion that will take place are: why is hypertension an important clinical condition, what causes hypertension, and what are some current innovative measures and/or programs to detect and manage hypertension for the individual as well as at a population level.

Earn CME Credit

SMJ Articles

July 2019
Prevalence of Systemic Hypertension Among HIV-Infected and HIV-Uninfected Young Adults in Baltimore, Maryland.
Ryscavage P, Still W, Nyemba V, Stafford K.

September 2018
Parental Age and the Risk of Gestational Hypertension and Preeclampsia.
Ortiz C, Rondeau NU, Moore LE, Mulla ZD.

March 2018
Standardized Hypertension Management to Reduce Cardiovascular Disease Morbidity and Mortality Worldwide.
Patel P, Ordunez P, Connell K, Lackland D, DiPette D; Standardized Hypertension Treatment and Prevention Network.

A playlist from our Youtube Channel of former presentations dealing with Hypertension/Heart Health.

New SMA Member Benefits

May 12, 2020 // Randy Glick

Akos Connect is a revolutionary telemedicine platform that allows physicians to diagnose and treat patients from their smartphone, tablet or desktop. With flexible, 24/7 access, our cloud based, HIPAA-compliant platform allows remote access so physicians can virtually consult with patients anytime, anywhere. Expand your geographical footprint to patients in rural or under- served areas that you would otherwise not be able treat. SMA Members receive 10% off monthly or annual subscriptions.

Identity theft insurance is designed to cover some of the costs that occur when someone steals your identity. It reimburses you for money spent on reclaiming your financial identities and repairing credit reports. Those costs can range from phone bills to legal help. Policies often provide specialists who can help guide victims through the identity restoration process.  On average a victim will spend 330 hours resolving and repairing identity theft.

SMJ : May 2020 Vol. 113, No. 05

May 5, 2020 // Randy Glick

The Southern Medical Journal is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists, including medicine; surgery; women’s and children’s health; mental health; emergency and disaster medicine; public health and environmental medicine; bioethics and medical education; and quality health care, patient safety, and best practices.

Midnight Report: A Novel Faculty-Guided Night Curriculum to Enhance Resident Nighttime Education
Jawad Al-Khafaji, MD, MSHA, Venkata Rajesh Konjeti, MD, Stephanie Call, MD, MSPH

Does Formal Training in Medical Education and Professional Development Lead to Better Career Outcomes for Clinician Educators?
Amar Kohli, MD, MS, Maggie Benson, MD, MS, Alexandra Mieczkowski, MD, MS, Carla Spagnoletti, MD, MS, Doris Rubio, PhD, Melissa McNeil, MD, Rosanne Granieri, MD

Virtue Ethics and the Physician: Aristotle’s Burnout Antidote?
Carolyn Ann Smith, MD, MPH

Perceived Barriers to Contraceptive Access and Acceptance among Reproductive-Age Women Receiving Opioid Agonist Therapy in Northeast Tennessee
Edward Leinaar, MPH, Bill Brooks, DrPH, Leigh Johnson, MD, MPH, Arsham Alamian, PhD, MSc

Keeping Children Safe at Home: Parent Perspectives to Firearms Safety Education Delivered by Pediatric Providers
Annalyn S. DeMello, MPH, RN, Eric H. Rosenfeld, MD, MPH, Brian Whitaker, PA, David E. Wesson, MD, Bindi J. Naik-Mathuria, MD, MPH

Geographic Variations of Racial/Ethnic Disparities in Late-Stage Diagnosis of Childhood Cancer in Texas
Niaz Morshed, PhD, Kelly Haskard-Zolnierek, PhD, F. Benjamin Zhan, PhD

National Estimates of Noncanine Bite and Sting Injuries Treated in US Hospital Emergency Departments, 2011–2015
Dariusz Hareza, MD, Ricky Langley, MD, PhD, Marilyn Goss Haskell, DVM, MPH, Katherine King, MPH

Frequency of Animal Leptospirosis in the Southern United States and the Implications for Human Health
Tyann Blessington, PhD, MPH, Anna P. Schenck, PhD, MSPH, Jay F. Levine, DVM, MPH

A Retrospective Study of Students Referred to a Psychiatric Clinic at a College Counseling Center in Appalachia
Brittani Lowe, MD, Kristina Bryant-Melvin, MD, Mark Peterson, MD, Nafeeza Hussain, MD, MPH, Suzanne Holroyd, MD

CME Article: Frequency of Care Fragmentation and Its Impact on Outcomes in Acute and Chronic Pancreatitis in a Nationally Representative Sample
Emad Qayed, MD, MPH, Ramzi Mulki, MD

Posted in: Mental HealthSMJSMJ ArticleWomen’s & Children’s Health

May is Mental Health Awareness Month

May 1, 2020 // Randy Glick

According to the National Alliance of Mental Health, 19.1% of U.S. adults experienced mental illness in 2018 (47.6 million people). This represents 1 in 5 adults.

Mental Health Perspective on Coronavirus

Dr. Anandhi Narasimhan will discuss issues related to mental health during the coronavirus pandemic. Topics include managing anxiety, how to deal with social distancing and isolation, how to talk to children about coronavirus. Also will discuss how treatment can be optimized so that mental health services are available to those who need it virtually.

Earn CME Credit

Fireside Chat: Treatment of Addiction and Maintaining Sobriety During a Time of Pandemic and Isolation

In this latest episode of Fireside Chats with the Troops on the Frontline of COVID-19 Pandemic, SMA President Dr. Philip Hartman, a family physician who treats chemical dependency is joined by Mike Foster, a licensed chemical dependency counselor, to discuss the struggles of treating addiction and maintaining sobriety during a pandemic. Helpful tools and resources for healthcare providers are also outlined.

Earn CME Credit

Fireside Chat: How Anxiety and Depression Have Changed in Our Patient Population (Coming Soon)

In this latest episode of Fireside Chats with the Troops on the Frontline of COVID-19 Pandemic, SMA President Dr. Philip Hartman and licensed therapist Jaclyn Replogle discuss how anxiety and depression have changed in the patient population throughout the COVID-10 pandemic and how providers might assist those patients. In addition, coping techniques, methods, and resources for both patients and healthcare providers are detailed.

Wellness Programs in an Academic Practice: Lessons Learned

The development of wellness programs in many groups is increasingly common as institutions work to address the issue of burnout and employee performance. Academic programs face a unique challenge establishing wellness plans because of the varied professional roles of individuals working together in a team model. The individuals in these groups are at different stages in their careers, with different priorities such as a focus on ongoing education, stable employment, or career advancement.

Commentary on “Wellness Programs in an Academic Practice: Lessons Learned”

We commend the authors of the Perspective entitled “Wellness Programs in an Academic Practice: Lessons Learned,” for highlighting the importance of resident wellness and for developing positive efforts to promote resilience in their resident cadre. The present climate in graduate medical education is one of striving to appreciate the challenges that resident physicians face as they train in a technologically intensive clinical environment while learning a rapidly expanding body of basic and applied medical science.

Changes in Health and Well-Being during Residents’ Training

Previous studies have characterized the negative effects of graduate medical education on physicians; however, there is limited longitudinal data on how physicians’ well-being changes during their training. This study aimed to demonstrate and quantify changes to trainees’ wellness and health habits during the course of their first 2 years of graduate medical education.

SMA Menu